Dr Nicole Lawrence
Dr

Nicole Lawrence

Email: 
Phone: 
+61 7 344 36298

Background

My research focuses on using host defence molecules as the basis for designing peptide-based drugs with improved safety and reduced likelihood of drug resistance to combat infectious disease caused by pathogenic bacteria and malaria parasites. Zooming in to investigate molecular interactions at the cell surface and inside infected cells allows me to describe and refine how drug candidates overcome disease organisms to produce the next generation of antimicrobial drugs.

Availability

Dr Nicole Lawrence is:
Available for supervision
Media expert

Fields of research

Biological Sciences Microbiology

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • Developing next generation medicines from antimicrobial peptides

    Developing new drugs from natures host defence molecules - with improved safety and less likely to induce drug resistance.

Search Professor Nicole Lawrence’s works on UQ eSpace

61 works between 1994 and 2026
All (61) Journal Article (54) Other Outputs (1) Conference Publication (5) Book Chapter (1)

61 - 61 of 61 works

1994

Journal Article

Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker

Prescott, N, Stowers, AW, Cheng, Q, Bobogare, A, Rzepczyk, CM and Saul, A (1994). Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker. Molecular and Biochemical Parasitology, 63 (2), 203-212. doi: 10.1016/0166-6851(94)90056-6

Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker

Past funding

  • 2022 - 2026
    Next-generation peptide-based medicines for malaria
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2022 - 2024
    Developing FXIIa inhibitors as next-generation anticoagulants
    NHMRC Development Grant
    Open grant
  • 2020 - 2023
    Developing targeted antimalarial drug leads from host defence peptide-drug conjugates (NHMRC Ideas Grant led by ANU)
    Australian National University
    Open grant

Availability

Dr Nicole Lawrence is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Completed supervision

Enquiries

Contact Dr Nicole Lawrence directly for media enquiries about:

  • drug design
  • drug-resistant bacteria
  • malaria
  • peptides
  • tropical health

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au